Title |
The Future of Immunotherapy: A 20-Year Perspective
|
---|---|
Published in |
Frontiers in immunology, November 2017
|
DOI | 10.3389/fimmu.2017.01668 |
Pubmed ID | |
Authors |
David C. Wraith |
Abstract |
Immunotherapy is the field of immunology that aims to identify treatments for diseases through induction, enhancement or suppression of an immune response. Immunotherapies designed to instigate or enhance an immune response are considered "activating immunotherapies" while those designed to repress an immune response are "suppressive immunotherapies." This perspective will focus on two areas of immunotherapy, activating immunotherapies for cancer and suppressive immunotherapies for autoimmunity both of which have seen a resurgence in interest in recent years and are likely to transform the treatment of many human diseases in the next 20 years. Effective immunotherapies for cancer, where the aim is to activate tumor-specific immune responses, will be totally different from those designed to suppress the immune response to self-antigens in autoimmune disease. Furthermore, the reader will appreciate that the degree to which side effects of immunotherapies are acceptable will differ drastically between life-threatening cancers and chronic, debilitating but not necessarily life-threatening autoimmune conditions. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 8% |
Venezuela, Bolivarian Republic of | 1 | 8% |
Ireland | 1 | 8% |
France | 1 | 8% |
Unknown | 8 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 11 | 92% |
Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 195 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 29 | 15% |
Student > Bachelor | 26 | 13% |
Researcher | 21 | 11% |
Student > Ph. D. Student | 17 | 9% |
Other | 10 | 5% |
Other | 24 | 12% |
Unknown | 68 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 36 | 18% |
Medicine and Dentistry | 17 | 9% |
Immunology and Microbiology | 16 | 8% |
Agricultural and Biological Sciences | 15 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 13 | 7% |
Other | 21 | 11% |
Unknown | 77 | 39% |